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Summary
The number of anaesthetists who are involved in
magnetic resonance (MR) units is increasing. Magnetic
resonance systems are becoming more powerful and
interventional procedures are now possible. This paper
updates information relating to safety terminology,
occupational exposure, reactions to gadolinium-based
contrast agents and the risk of nephrogenic systemic
ﬁbrosis. Magnetic resonance examinations of patients
with pacemakers are still generally contra-indicated but
have been carried out in specialist centres under strictly
controlled conditions. As availability of MR increases, so
the education of anaesthetists, who are occasionally
required to provide a service, must be considered.
Anaesthesia in MR units was ﬁrst described in the
1980s. Guidelines on the provision of anaesthetic services
in MR units were published by the Association of
Anaesthetists of Great Britain and Ireland (AAGBI) in
2002 [1]. Since then, the number of hospitals with MR
units, and hence the number of patients requiring
anaesthesia for MR, has increased. While the issues
relating to setting up anaesthetic services in MR have not
changed, there have been a number of developments that
warrant this update:
1 Safety terminology and guidelines have changed.
2 MR systems utilise higher magnetic-ﬁeld strengths
and more open designs are available.
3 Interventional and intra-operative MR are now
routine in some centres.
4 Mobile MR scanners are increasingly used to reduce
waiting lists.
5 Although still generally contra-indicated, some
patients with pacemakers have been scanned under
strictly controlled conditions in specialist centres.
6 ‘MR safe’ medical implants are now being produced.
7 New equipment is now available for use in MR.
8 Out-of-hours availability of MR investigations has
increased.
9 Reports of allergic reactions to MR contrast media
have increased.
10 Gadolinium based contrast agents (Gd-CAs) are
associated with a varying degree of risk of nephro-
genic systemic ﬁbrosis in patients with impaired renal
function.
Safety guidelines and legislation
In 2007 the Medicines and Healthcare products Regu-
latory Agency (MHRA) updated safety guidance as a
Device Bulletin [2]. Three terms are now to be used as
standard in an attempt to remove any ambiguity caused by
the old MR compatible system. These terms are MR
conditional, MR safe and MR unsafe. MR conditional
refers to an item that has been demonstrated to pose no
known hazards in a speciﬁed MR environment with
speciﬁed conditions of use. Many items in the MR
environment will now be marked as MR conditional, and
the conditions under which they can be safely used must
accompany the device. This change of terminology has
come about because of reports of injuries and problems
with MR compatible equipment [3]. Conditions that
deﬁne the speciﬁed MR environment include main
magnetic ﬁeld strength, spatial magnetic ﬁeld gradient,
dB ⁄dt (time rate of change of the magnetic ﬁeld), radio
frequency (RF) ﬁeld strength, and speciﬁc absorption
rate. Additional conditions, including speciﬁc conﬁgura-
tions of the item of equipment, may be required.
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safety hazard to patients or personnel when it is taken into
the MR examination room, provided that instructions
concerning its use are correctly followed. This does not,
however, guarantee that it will function normally and not
interfere with the correct operation of the MR imaging
equipment, with degradation of image quality.
New equipment, such as infusion pumps [4], warming
mattresses and temperature probes are now available. It is
important to understand the manufacturers’ instructions
of all equipment that is brought into the vicinity of the
MR scanner.
It should be recognised that the supervising MR
radiographer is responsible operationally for MR safety
within the controlled area and that anaesthetic staff
should defer to him/her in relation to MR safety matters,
in particular control of access of staff and equipment into
the controlled area. Where staff are given access codes or
swipe-card access to the controlled area, they should not
be shared with others, nor should they provide access to
others unless speciﬁcally authorised to do so.
Inspired oxygen concentration
The use of 100% O2 during anaesthesia should be
reported to the reporting radiologist as this can produce
an artefact in the form of an abnormally high signal in
cerebrospinal ﬂuid (CSF) spaces in the T2 weighted ﬂuid
attenuated inversion recovery (FLAIR) sequence.
Acoustic noise
The time-varying magnetic ﬁeld gradients produce
audible noise within the magnet interior. Since the
guidelines were published by the AAGBI, the Control of
Noise at Work Regulations have been updated [5]. This
document introduced lower exposure limit values and
action values in the working environment. When the
noise level exceeds 80 dB (A), it is recommended that
staff and others remaining in the scanning room should
wear ear protection.
Other documents have been published by the Health
Protection Agency relating to patient exposure guidance
[6] and static ﬁeld guidance [7]. The website of the British
Association of MR Radiographers (BAMRR) remains an
excellent resource for safety issues and provides links to
many useful safety sites [8].
New MR systems
At the end of 2006, it was estimated that there were
approximately 500 ﬁxed MR scanners involved in human
imaging, installed at some 350 sites across the UK [6]. The
SI unit of magnetic ﬁeld strength or magnetic ﬂux density
is the Tesla (T) and initially, most clinical MR systems
were 0.5, 1.0 or 1.5 T. In 1992 there were two MR units
in Northern Ireland. Today there are 16, of which, one is
a 3-T system. Other regions will have experienced a
similar expansion but, since the withdrawal of funding
from MagNET, up-to-date information for the UK is
difﬁcult to obtain.
Magnets operating at 3 T appeared in the early 1990s
and by 2007 it was estimated that 35 units had installed
3-T systems [5]. The beneﬁts of the higher ﬁeld strength
systems include improved image quality and higher spatial
resolution. While it is claimed that 3-T scans are quicker,
more efﬁcient and require less Gd-CAs, practically these
statements are debatable. It is the responsibility of the
equipment manufacturers to indicate the ﬁeld strength at
which their equipment is MR safe or MR conditional. It
should not be automatically assumed that equipment that
is MR conditional at 1.5 T remains MR conditional at
3 T. A smaller number of ultra-high ﬁeld MR systems are
in use in research institutions world wide and these
produce static ﬁelds in the range 4.7–9.4 T [6]. Anaes-
thetists may wish to be aware of the potential implications
of replacing a 1.5-T system by a 3-T system. In a
magnetic ﬁeld strength survey of a 1.5-T system all spot
measurements taken at 1 m above the ﬂoor level were
found to be below the 0.5-mT safety limit. A similar
survey for a 3-T system indicated that there were areas
outside the magnet room where levels exceeded the safety
limit. Barriers and warning notices, which indicate the
risk of pacemaker malfunction, should be in place to
prevent inadvertent public access.
Open systems
The horizontal-bore cylindrical type of scanner is still the
commonest, but technology constantly changes and
magnets are available with wider bores, which are less
claustrophobic. More open scanners have been developed
and units now exist that allow the patient to stand upright
thus reducing the feeling of claustrophobia. In a conven-
tional MR system operating at 1.5 T, because of its more
closed design, it is less likely that radiological and
anaesthetic staff would be exposed to signiﬁcant static
and time varying ﬁelds.
Interventional procedures and intra-operative MR
Advances in technology mean MR image-guided surgery
is now possible, providing the surgeon with dynamic
high-resolution images during intricate stereotactic neu-
rosurgery. Various MR systems have been conﬁgured for
this application, including ‘doughnut’ shaped magnets
permitting surgery with real-time concurrent imaging,
and portable systems set up to allow easy and rapid
interchange between scanning and surgery. All the
hazards associated with diagnostic MR also apply to
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patient repositioning, contamination of the sterile ﬁeld,
and the proximity of ferromagnetic surgical instruments,
including scalpels, to the magnetic ﬁeld. Incorporating
MR technology into the operating room provides new
challenges [9].
Occupational exposure
It is difﬁcult to measure occupational exposure to the
various electro magnetic ﬁelds in MR units routinely.
Personal dosimeters have been developed but are not, as
yet, widely available. Some studies have suggested that
staff members can be exposed to higher than recom-
mended levels of time-varying gradient ﬁelds [10, 11]. In
2004, the European Union adopted a directive restricting
occupational exposure to electromagnetic ﬁelds, includ-
ing those used in MR. Some of the exposure limits
threatened to impact on the current use and future
development of MR technology. Known adverse effects
are adequately addressed in the international standard
governing the manufacture of MR systems. Initially,
unable to inﬂuence the regulatory agencies, the MR
community began to lobby both the UK and European
Parliaments. Implementation of the directive has been
delayed until 30 April 2012 to allow a permanent solution
to be found. However, the timescale is short given the
political and scientiﬁc complexities of the issue. A range
of possible outcomes is explored in a report for the
Institute of Physics [12]. Each option has advantages and
disadvantages, and a great deal of detailed discussion and
negotiation will be needed over the next 2 years to ensure
satisfactory resolution of the problem.
Pacemakers and medical implants
The MHRA safety guidance [2] still speciﬁes that
pacemakers are an absolute contraindication to MR and
it therefore remains the mantra of radiology departments
that any individual with a pacemaker should not enter the
MR unit. This is due to the concern that the magnet ﬁeld
strengths in excess of 0.5 mT (5 Gauss) could cause a fatal
malfunction of the pacemaker. Sudden deaths have been
reportedinpatientswithpacemakersduringorshortlyafter
MRinvestigations[13,14].However,bothpacemakerand
MR technology are continually developing and there are
times when MR is needed to provide valuable clinical
information in patients with pacemakers. There have
been a small number of cases when a patient with a
non-compatible pacemaker has required MR imaging.
Approximately two million Europeans have implanted
pacemakers, but these patients are strongly discouraged
from receiving MRI scans. According to estimates, 50–
75% of patients world-wide with implanted cardiac
devices are expected to need a MR scan during the
lifetime of their device [15]. Editorials in the American
and European literature concluded that the risk:beneﬁt
ratio for patients with pacemakers undergoing MR has
shifted towards safety, if guidelines are followed [16, 17].
Discussion in the correspondence sections has been
generated [18]. In summary, the presence of a permanent
pacemaker no longer represents a strict contra-indication
to MR in carefully selected clinical circumstances
provided that speciﬁc strategies are followed [19].
MR compatible pacemakers are now available and
have been implanted in some patients. One pacemaker
manufacturer has received a Conformite ´ Europe ´enne
(CE) Mark for its second-generation MR safe pacing
system. However, approval has not yet been forthcoming
from the Food and Drug Administration in the USA [20].
Programmable shunts
The pressure setting of programmable hydrocephalus
shunts may be unintentionally changed by the magnetic
ﬁeld leading to over- or under-drainage of CSF. If these
patients are to undergo an MR examination, a program-
mer and a trained clinician should be available to verify
the correct setting and to reprogram the device, if
required, immediately following the MR procedure.
Advice must be given to the patient on how to recognise
over- and under-drainage and whom to contact should
these conditions develop [2].
Neurostimulators
A wide variety of neurostimulators are now in use.
Concerns about MR safety relate to the RF and gradient
ﬁelds that may interfere with the operation of these
devices or cause thermal injury. It is recommended that
patients implanted with neurostimulators should not
undergo MR. However, some manufacturers are sug-
gesting that MR examinations of speciﬁc devices may be
safe if strict guidelines relating to scanning parameters, in
particular to RF exposure, are followed [2].
Out-of-hours MR imaging
There are many indications for urgent MR imaging, but
they can be grouped into two main areas: suspected spinal
cord or cauda equina compression; and investigation of
acute neurological conditions. Hospital trusts have faced
litigation when treatment has been delayed due to lack of
24-h MR availability. Patients in intensive care units
(ICUs) who require urgent MR will need to be
accompanied by anaesthetic staff. Intensive care patients
have additional sources of hazard including central lines
and intracranial pressure transducers [21]. Screening
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should be remembered that the ultimate operational
responsibility for safety issues remains with an appropri-
ately trained MR Authorised Person (usually the super-
vising radiographer) and the MR radiologist [2].
Training
Training requirements for any staff entering the MR unit
are detailed by the MHRA [2]. The responsibility for
safety training lies with the MR Responsible Person who
may be the clinical director, head of department, clinical
scientist or MR superintendent radiographer. The unit’s
MR Safety Advisor should provide technical advice. The
wide range of staff from differing disciplines who need
access to the MR environment have been designated into
categories. Anaesthetists fall into MHRA category B; that
is, they may be present with a patient in the MR
controlled area during scanning. They should be aware of
safety aspects related to the main static magnetic ﬁelds, RF
ﬁelds, gradient magnetic ﬁelds and electrical safety of
equipment. They must understand the signiﬁcance of the
MR controlled area and the inner MR controlled area.
They should be familiar with emergency procedures
arising from causes other than equipment failure and
should be aware of the need to evacuate the patient from
the inner controlled area in order to deal with emergency
resuscitation. Training also includes an understanding of
the projectile effect and the inﬂuence of the magnetic ﬁeld
upon medical implants, prostheses and personal effects.
Anaesthetists should understand the consequences of
quenching of super-conducting magnets, and be aware of
the recommendations on exposure to MR and the need
for ear protection.
How can these training requirements be met? The
potential for e-learning should be considered. The Royal
College of Anaesthetists includes the physics of MRI in its
basic science syllabus [22]. Trainees who have completed
an e-learning module and attended an elective MR list
would then be certiﬁed as suitable to accompany ICU
patients for MR imaging. Regular reviews of training
status as well as updates and refresher courses will be
required. Hospitals will wish to apply local rules regarding
consultant supervision of anaesthetic trainees in MR units.
Contrast reactions
Gadolinium-based contrast agents are used in MR for
demonstration of vascular structures or to improve
contrast resolution of tissues. In comparison with other
radiological contrast agents, Gd-CAs are relatively safe
with a high therapeutic ratio and low incidence of
anaphylaxis (approximately 1:100 000). The side-effects
of Gd-CAs are generally mild and include headache,
nausea and vomiting, local burning, skin wheals (2%),
itching, sweating, facial swelling and thrombophlebitis
[23]. More severe reactions have occurred and radiology
staff should be familiar with guidelines related to the
management of suspected anaphylaxis [24].
Nephrogenic systemic ﬁbrosis
There has been recent attention to reports that patients
with renal failure are at risk of developing a rare,
potentially life-threatening condition with Gd-CAs called
nephrogenic systemic ﬁbrosis or nephrogenic ﬁbrosing
dermopathy (NSF ⁄NFD). The glomerular ﬁltration rate
(GFR) should be estimated in all patients with kidney
disease to identify those at risk of developing NSF ⁄NSD.
If the GFR is estimated at less than 30 ml.min
)1 per
1.73 m
)2, the risk of Gd-CAs should be balanced against
beneﬁt, and a minimal dose of Gd-CAs only administered
if an unenhanced scan proves insufﬁcient [25]. The
Gd-CA should not be administered again for at least
7 days. Current evidence suggests that contrast agents may
be classiﬁed as high-risk, e.g. gadopentelic acid, medium-
risk, e.g. gadobenic acid, and low-risk e.g. gadoteridol
[26]. The use of high-risk agents is contra-indicated in
neonates and during the peri-operative period in patients
undergoing liver transplantation. The Gd-Cas are not
recommended in pregnancy unless absolutely necessary.
Conclusions
While some safety terminology has altered, the basic
recommendations for provision of anaesthetic services in
MR units have remained the same since ﬁrst published in
2002 [1]. Anaesthetists who are involved with 3-T
systems, open scanners or interventional and intra-
operative procedures should remain acquainted with the
constantly changing recommendations relating to occu-
pational exposure. They should take all practical steps to
minimise the risk from exposure. MR examinations of
patients with pacemakers are no longer absolutely contra-
indicated but may be carried out under strictly controlled
conditions in exceptional cases. Increased requirements
for MR imaging in intensive care and postoperative
patients have increased the need for repeated training.
The employment of e-learning modules may facilitate
such training. There has been an increase in the number
of allergic reactions to Gd-CAs and it is recognised that
patients with renal failure are at risk of developing NSF.
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